
Christin Weissleder
Current Appointments
Post Doctoral FellowFollowing completion of her Bachelor of Science in Biological Science, Christin obtained her Master of Science in 2013 in Molecular Medicine from the Friedrich Schiller University Jena, Germany, majoring in pharmacology and pathology. During her Master Thesis, she investigated the coupling of brain stimulation reward, adult neurogenesis and learning in collaboration with the Leibniz Institute for Neurobiology in Magdeburg, Germany.
Christin joined the Schizophrenia Research Laboratory as a visiting researcher in 2014 and relocated to Australia in 2015 to start her PhD. She investigates age-related changes of neurogenesis and associated molecular factors in healthy humans across the entire lifespan. Christin also examines whether there are differences in neurogenesis and associated molecular factors in the brains of healthy adults compared to patients with schizophrenia. Her research will be important to advance our understanding of the underlying molecular causes of this disease and may help to explain some of the symptoms, such as working memory deficits.
Publications
2025 Jan
Divergent changes in complement pathway gene expression in schizophrenia and bipolar disorder: Links to inflammation and neurogenesis in the subependymal zone
View full journal-article on http://dx.doi.org/10.1016/j.schres.2024.11.005
2024, 04 May
RNA-sequencing suggests extracellular matrix and vasculature dysregulation could impair neurogenesis in schizophrenia cases with elevated inflammation
View full journal-article on http://dx.doi.org/10.1038/s41537-024-00466-0
2024 Feb
Sex- and suicide-specific alterations in the kynurenine pathway in the anterior cingulate cortex in major depression
View full journal-article on http://dx.doi.org/10.1038/s41386-023-01736-8
2022 Oct
Increased immune cell and altered microglia and neurogenesis transcripts in an Australian schizophrenia subgroup with elevated inflammation
View full journal-article on http://dx.doi.org/10.1016/j.schres.2022.08.025
2022, 07 Jan
Identifying gene expression profiles associated with neurogenesis and inflammation in the human subependymal zone from development through aging
View full journal-article on http://dx.doi.org/10.1038/s41598-021-03976-4
2021, 15 Dec
A schizophrenia subgroup with elevated inflammation displays reduced microglia, increased peripheral immune cell and altered neurogenesis marker gene expression in the subependymal zone
View full journal-article on http://dx.doi.org/10.1038/s41398-021-01742-8
2021 Dec
Reductions in midbrain GABAergic and dopamine neuron markers are linked in schizophrenia
View full journal-article on http://dx.doi.org/10.1186/s13041-021-00805-7
2021, 08 Jul
Reduced insulin-like growth factor family member expression predicts neurogenesis marker expression in the subependymal zone in schizophrenia and bipolar disorder
View full journal-article on http://dx.doi.org/10.1093/schbul/sbaa159
2021, 31 May
Reduced adult neurogenesis is associated with increased macrophages in the subependymal zone in schizophrenia
View full journal-article on http://dx.doi.org/10.1038/s41380-021-01149-3
2020, 29 Sep
Increased macrophages and C1qA, C3, C4 transcripts in the midbrain of people with schizophrenia
View full journal-article on http://dx.doi.org/10.3389/fimmu.2020.02002